Nadolol
Nadolol is a generic beta-adrenergic blocker medication available as oral tablets in 20mg, 40mg, and 80mg strengths. Manufactured by Aurobindo Pharma Limited, it is prescribed to treat conditions like high blood pressure, angina, and certain heart rhythm disorders by blocking beta receptors in the body. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Nadolol is a generic beta-adrenergic blocker medication available as oral tablets in 20mg, 40mg, and 80mg strengths. Manufactured by Aurobindo Pharma Limited, it is prescribed to treat conditions like high blood pressure, angina, and certain heart rhythm disorders by blocking beta receptors in the body. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Nadolol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Nadolol — ANDA 211763 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211763"
}
]
|
| identifier | ANDA211763 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Nadolol |
